Progress in ophthalmology depends not only on innovation, but on the structures that allow innovation to be tested, validated, and translated into clinical care. An
Experts explain how screen time affects the cornea and tear film, why the retina is not harmed, and what helps protect eye health.
Prof. Farhad Hafezi from the ELZA Institute provided an insightful update on the Second Global Consensus on Keratoconus during an interview with EyeTube.
In a recently published case report in American Journal of Ophthalmology Case Reports, our team, in collaboration with Brazilian colleagues, describes an unusual case of a “CTK-like syndrome” following sequential intracorneal ring segment (ICRS) implantation and corneal cross-linking (CXL) in a young patient with progressive keratoconus.
Recent corneal cross-linking advances extend beyond disease stabilization, introducing individualized and second-generation customized treatment approaches for keratoconus.
Innovations in Corneal Cross-Linking (CXL): A Look at 25 Years of Progress
Nikki Hafezi, a partner of MESCA Foundation, is leading healthcare transformation in Uzbekistan. MESCA, founded in 2021 by Bakhtiyor Fazylov, focuses on medical education, training, and research. It aims to enhance ophthalmological care, particularly addressing keratoconus, a significant cause of preventable blindness in children. MESCA’s initiatives include training local healthcare professionals and collaborating with institutions like the Andijan State Medical Institute to improve medical practice and education.
When considering eyelid surgery, choosing an oculoplastic surgeon ensures specialized care for both cosmetic and functional outcomes. With extensive training in ophthalmology and plastic surgery, oculoplastic surgeons offer unparalleled expertise in the periorbital region. Discover why an oculoplastic surgeon should be your top choice for safe, precise, and aesthetically pleasing results.
Discover the latest advancements in keratoconus treatment with the ELZA Institute’s innovative techniques: transPRK, PACE, and All Femto-CAIRS, as featured in The Ophthalmologist.